Gennova Biopharmaceuticals becomes a fully owned subsidiary of Emcure as a result of this strategic acquisition, centralising the group's biopharmaceutical, complex biologics, and biosimilar operations.
Gennova Biopharmaceuticals becomes a fully owned subsidiary of Emcure as a result of this strategic acquisition, centralising the group's biopharmaceutical, complex biologics, and biosimilar operations.
<iframe src="https://hindustansphere.com/embed/cluster/fca09e142b0d3e16e2909b2959fcac62d4ebe776" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Emcure Takes 100% Control Of Biopharma Arm Gennova, Buys Minority Stake Held By Dr Sanjay Singh, Others"></iframe>
